Continued administration of pembrolizumab for adenocarcinoma of the lung after the onset of fulminant type 1 diabetes mellitus as an immune‐related adverse effect: A case report

por Edahiro, Ryuya, Ishijima, Mikako, Kurebe, Hiroyuki, Nishida, Kohei, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Mori, Masahide
Publicado 2019

Hyperprogressive disease in patients with non‐small cell lung cancer treated with nivolumab: A case series

por Kanazu, Masaki, Edahiro, Ryuya, Krebe, Hiroyuki, Nishida, Kohei, Ishijima, Mikako, Uenami, Takeshi, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Publicado 2018

Safety and effectiveness of pirfenidone combined with carboplatin‐based chemotherapy in patients with idiopathic pulmonary fibrosis and non‐small cell lung cancer: A retrospective...

por Yamamoto, Yuji, Yano, Yukihiro, Kuge, Tomoki, Okabe, Fukuko, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yamaguchi, Toshihiko, Mori, Masahide
Publicado 2020

EGFR‐mutant lung adenocarcinoma associated with antisynthetase syndrome successfully treated with osimertinib

por Hara, Reina, Kanazu, Masaki, Iwai, Ami, Kuge, Tomoki, Ishijima, Mikako, Uenami, Takeshi, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Publicado 2021

Expectoration of tonsillar metastasis of pulmonary pleomorphic carcinoma after pseudoprogression: A case report

por Kuge, Tomoki, Okabe, Fukuko, Yamamoto, Yuji, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Yamaguchi, Toshihiko, Mori, Masahide
Publicado 2021

Case series of pleomorphic carcinomas of the lung treated with nivolumab

por Kanazu, Masaki, Uenami, Takeshi, Yano, Yukihiro, Nakatsubo, Saeko, Hosono, Yuki, Ishijima, Mikako, Akazawa, Yuki, Yamaguchi, Toshihiko, Urasaki, Koji, Mori, Masahide, Yokota, Soichiro
Publicado 2017

Radiation Pneumonitis with Eosinophilic Alveolitis in a Lung Cancer Patient

por Hosono, Yuki, Sawa, Nobuhiko, Nakatsubo, Saeko, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yano, Yukihiro, Mori, Masahide, Yamaguchi, Toshihiko, Yokota, Soichiro
Publicado 2017

Post-progression survival after cessation of treatment with nivolumab for advanced non-small cell lung cancer: A retrospective study

por Yano, Yukihiro, Kurebe, Hiroyuki, Edahiro, Ryuya, Hosono, Yuki, Nakatsubo, Saeko, Nishida, Kohei, Sawa, Nobuyuki, Ishijima, Mikako, Uenami, Takeshi, Kanazu, Masaki, Akazawa, Yuki, Yamaguchi, Toshihiko, Mori, Masahide
Publicado 2018

Clinical implications of monitoring nivolumab immunokinetics in non–small cell lung cancer patients

por Osa, Akio, Uenami, Takeshi, Koyama, Shohei, Fujimoto, Kosuke, Okuzaki, Daisuke, Takimoto, Takayuki, Hirata, Haruhiko, Yano, Yukihiro, Yokota, Soichiro, Kinehara, Yuhei, Naito, Yujiro, Otsuka, Tomoyuki, Kanazu, Masaki, Kuroyama, Muneyoshi, Hamaguchi, Masanari, Koba, Taro, Futami, Yu, Ishijima, Mikako, Suga, Yasuhiko, Akazawa, Yuki, Machiyama, Hirotomo, Iwahori, Kota, Takamatsu, Hyota, Nagatomo, Izumi, Takeda, Yoshito, Kida, Hiroshi, Akbay, Esra A., Hammerman, Peter S., Wong, Kwok-kin, Dranoff, Glenn, Mori, Masahide, Kijima, Takashi, Kumanogoh, Atsushi
Publicado 2018